A systematic review of alternative surveillance approaches for lymphatic filariasis in low prevalence settings: Implications for post-validation settings-Reference-Cited by-同舟云学术

A systematic review of alternative surveillance approaches for lymphatic filariasis in low prevalence settings: Implications for post-validation settings

Published:2020-05-12 Issue:5 Volume:14 Page:e0008289
ISSN:1935-2735
Container-title:PLOS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Riches Nicholas^ORCID,Badia-Rius Xavier^ORCID,Mzilahowa Themba,Kelly-Hope Louise A.

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference58 articles.

1. Global programme to eliminate lymphatic filariasis: progress report, 2017;WHO;Wkly. Epidemiol. Rec,2018

2. WHO. Lymphatic filariasis: Key facts 2019 [30 July 2019]. Available from: https://www.who.int/news-room/fact-sheets/detail/lymphatic-filariasis.

3. Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease;KD Ramaiah;PLoS Negl Trop Dis,2014

4. WHO. Global Programme to Eliminate Lymphatic Filariasis. Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. 2011. Available from: https://apps.who.int/iris/bitstream/handle/10665/44580/9789241501484_eng.pdf?sequence=1.

5. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka;RU Rao;PLoS Negl Trop Dis,2019

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphatic filariasis antigen and microfilaria epidemiology in Samoa in 2019, six months post triple-drug mass drug administration;2024-08-26

2. Operational research to inform post-validation surveillance of lymphatic filariasis in Tonga study protocol: History of lymphatic filariasis elimination, rational, objectives, and design;PLOS ONE;2024-08-20

3. Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact assessment;PLOS Neglected Tropical Diseases;2024-07-08

4. Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact surveillance;2024-01-30

5. Morbidity hotspot surveillance: A novel approach to detect lymphatic filariasis transmission in non-endemic areas of the Tillabéry region of Niger;Parasite Epidemiology and Control;2023-05